1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats
(
- Contribution to journal › Article
-
Mark
Precision mapping of gene expression and proteins in the brain using gene editing and barcoded viral vectors
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2022
-
Mark
Editorial : Gene therapy 2.0: Biotechnology for circuit engineering and complex therapeutic approaches
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits
(
- Contribution to journal › Article
- 2021
-
Mark
Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study
(
- Contribution to journal › Article
-
Mark
Functional Assessment of Direct Reprogrammed Neurons In Vitro and In Vivo
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2018
-
Mark
Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum
(
- Contribution to journal › Article
-
Mark
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease
(
- Contribution to journal › Article
- 2017
-
Mark
Gene therapy for Parkinson's disease : Disease modification by GDNF family of ligands
(
- Contribution to journal › Scientific review
-
Mark
Interaction between subclinical doses of the Parkinson's disease associated gene, α-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats
(
- Contribution to journal › Article